Letter to the Editor: Enhancing the rigor and impact of cholangiocarcinoma research: Addressing key concerns in the PTPN9-FGFR2 interaction study. [PDF]
Zhu M+5 more
europepmc +1 more source
Factors associated with the publication and impact of CUA abstracts over the last decade. [PDF]
Al-Daqqaq Z+5 more
europepmc +1 more source
Toripalimab combined with bevacizumab plus chemotherapy as first-line treatment for refractory recurrent or metastatic cervical cancer: a single-arm, open-label, phase II study (JS001-ISS-CO214). [PDF]
Li C+10 more
europepmc +1 more source
New integrations in patient care: the role of the pharmacist between couselling and medication adherence. [PDF]
Ciliberti R, Bonsignore A.
europepmc +1 more source
Institutionalization of Health Technology Assessment of medical devices: a cluster analysis of EU, EEA, and EFTA countries. [PDF]
Nurchis MC+6 more
europepmc +1 more source
Ultrafast infrared nano-imaging of local electron-hole dynamics in CVD-grown single-walled carbon nanotubes. [PDF]
Nishida J+4 more
europepmc +1 more source
Geographical inequities in cervical cancer screening coverage in Bolivia: a spatial nationwide ecological study. [PDF]
Huanca Challgua C+4 more
europepmc +1 more source
Correspondence to editorial on "Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting". [PDF]
Du S, Wisskirchen K, Zhang K, Protzer U.
europepmc +1 more source
Activation of Immune Responses Through the RIG-I Pathway Using TRITC-Dextran Encapsulated Nanoparticles. [PDF]
Baek H+10 more
europepmc +1 more source
Standardization in the management of gram-negative bloodstream infections after implementation of a clinical care guideline at a large academic, safety-net institution: a quasi-experimental study. [PDF]
Deaney MA+5 more
europepmc +1 more source